We use cookies to collect anonymous data to help us improve your site browsing experience.

Click 'Accept all cookies' to agree to all cookies that collect anonymous data. To only allow the cookies that make the site work, click 'Use essential cookies only.' Visit 'Set cookie preferences' to control specific cookies.

Set cookie preferences

Your cookie preferences have been saved. You can change your cookie settings at any time.

Publication - Research and analysis

US Export Plan - Sector Report - Pharmaceutical Services

Published
18 June 2026
From
Director of International Trade and Investment
Directorate
International Trade and Investment Directorate
Topic
Business, industry and innovation, Economy, International
ISBN
9781807752972

This is one of 8 sector reports that outlines the background research and analysis prepared in support of the US Export Plan and looks to identify the key opportunities in the USA for Scottish companies in this sector.

View supporting documents Supporting documents

Footnotes

1 Fraser of Allander Institute - The economic contribution of the Pharmaceuticals Sector in Scotland (2023)

2 A Trading Nation - Life Sciences Sector: export plan

3 Advanced Cell & Gene Therapy CDMO Solutions | RoslinCT

4 Fraser of Allander Institute - The economic contribution of the Pharmaceuticals Sector in Scotland (2023)

5 Pharmaceutical Contract Manufacturing Market Size & Growth Forecast to 2030

6 U.S. Biotechnology And Pharmaceutical Services Outsourcing Market | Industry Report, 2030

7 The Healthcare Debate: Will AI Threaten Clinicians Or Be Their Ally? - Forbes

8 Trends Shaping Biopharma in 2025 | Deloitte US

9 Pharma Supply Chains in 2025: What Will It Take to Build True Resilience? - AZO Life Sciences

10 Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve – The White House

11 Building a Resilient Domestic Drug Supply Chain: The path to national health security - API Innovation Center (2025)

12 Scottish Government FOI - Scottish direct exposure to US exports 2024 data

13 A Trading Nation: An Export Plan for Scotland’s Life Sciences Sector

14 Top Exporters of Medicinal and Pharmaceutical Products to the U.S. in 2024 - Voronoi

15 Pharmaceutical industry trends 2025, outlook and strategies | ZS

16 US Drug Discovery Market Size to Reach USD 61.2 Bn by 2034 | DMR

17 United States Active Pharmaceutical Ingredients (APIs) Market Research Report 2025-2033: Growth Driven by Generic Drug Growth, Biotech API Innovation, and Rising Investments in Advanced Manufacturing

18 Pharmaceutical Contract Manufacturing Market Size & Growth Forecast to 2030

19 U.S. Oncology Market to Surge from USD 81.34 Billion in 2025 to USD 211.78 Billion by 2034, Driven by Rising Cancer Burden

20 Biosimilars in the United States 2023-2027 - IQVIA

21 Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche

22 Pharma Services and Technology Market Update | 2025

23 Drug Supply Chain Security Act (DSCSA) | FDA

24 What must I do to import a human drug product that has been approved by the FDA into the US? | FDA

25 How Do Drugs Get Approved (and Fast-Tracked) by the FDA? | LUNGevity Foundation

26 Importing Pharmaceuticals Into The U.S. | USA Customs Clearance

27 Cold Chain Express Shipping for Pharmaceuticals: 2025 Guide & Trends - tempk

28 UK-US Economic Prosperity Deal: Zero-Tariff Pharmaceuticals and the Customs Compliance Framework Exporters Must Master | Customs-Declarations.UK

29 TMC BioBridge

30 Amid an onshoring push, Raleigh is poised to be pharma’s next manufacturing hub | PharmaVoice

31 Life Sciences - NJEDA

32 Top 10 U.S. Biopharma Clusters 2024

33 BioHealth Capital Region Retains #3 Spot in GEN’s Top U.S. Biopharma Clusters

Contact

Email: William.Gray@gov.scot

Back to top